ChromoGenics AB (publ)) sees growing demand for ConverLight™ dynamic glass for solar control and increases production volumes. Mats Wahl has been appointed Production Development Manager. Mats adds extensive technical industrial expertise to ChromoGenics.
Mats has had technical operational roles in which he successfully developed and implemented cost-effective production processes as well as introduced lean concepts to ensure efficient and quality-assured production. Mats comes from Munters Europe AB, Uppsala, where he worked as Production Manager.
"We are very pleased to have Mats with us to ensure high-yield production processes. Mats has a deep industrial background focusing on quality and efficiency throughout the production process to installation at the customer, says Micael Hamberg, COO for ChromoGenics. "We are in an exciting growth phase. With Mats' extensive experience, he will together with the supply chain organisation drive technical processes in line with increasing volumes to ensure a high quality delivery precision to our customers."
"I look forward to contributing to ChromoGenics’ processes within the supply chain," says Mats Wahl. "ConverLight™ Dynamic Glass for solar control is an interesting product of the time with high value for sustainability. It is exciting to participate in and contribute to the growth journey and ensure cost-effective production processes for larger volumes, "summarizes Mats.
Thomas Almesjö, CEO
Susanne Andersson, CFO & Head of Communications
Tel: +46 18 430 0430
ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.